weak nim contract overdon maintain buy
maintain buy rate revis ep
estim adjust pt lower
nim off-set lower expens nim
peer point econom cycl
compani prudent loan growth launch
new deposit gather vertic focus effici
profit recent price weak repres buy
opportun view jennif demba
earn preview ep street
vs vs
vs in-lin shpg model
assum us major biopharma sale benefit robust
outperform vs
defens rotat catalyst hh posit rebat
reimburs environ confer strong
dri powder remain favorit
fx season trade horizon lower
estim reflect recent advers fx move compani
use hedg off-set currenc move chang
view direct correct exact remain confid
underli stori model adjust today
sole fx estim includ pend spectrum
batteri acquisit nr close
result chang lower
ep estim maintain
price target ebitda in-lin peer buy
 today inventori report bearish energi
stock crude inventori build off-set declin
gasolin distil inventori week sharp declin
crude export kbpd possibl relat hurrican michael
season low refineri util may account week
mmbbl product draw mmbbl higher week/
week mmbbl greater averag build
net crude grew kbpd net product export increas
kbpd week ken sill
bdc bdc preview- favor name company-specif
upsid
electr power util power/ util model updat
thud
fx season trade horizon lower
estim reflect recent advers fx move compani
use hedg off-set currenc move chang
view direct correct exact remain confid
underli stori model adjust today
sole fx estim includ pend spectrum
batteri acquisit nr close
result chang lower
ep estim maintain
price target ebitda in-lin peer buy
consum stapl lower estim advers fx
move lower estim sever multi-national
compani base recent advers fx movement
view new news estim near high
street sever compani peer alreadi
revis number lower howev want reset
bar compani report next
month chang rate price
fertitta propos revers merger caesar initi thought
rubbl maintain pt maintain
ep estim follow encourag print
increasingli optimist abl navig
sever current industri headwind via market share
gains/oper effici remain favorit way
play rv space n-t maintain pt michael
lodg overal revpar y/i week
end per str lower prior week result
stack revpar vs
prior week independ hotel data set
y/i midscal strongest chain scale
brand hotel luxuri weakest upper
midscal also under-perform industri averag
prior week stronger transient vs
electr power util
electr power util ali agha
 today inventori report bearish energi
stock crude inventori build off-set declin
gasolin distil inventori week sharp declin
crude export kbpd possibl relat hurrican michael
page
season low refineri util may account week
mmbbl product draw mmbbl higher week/
week mmbbl greater averag build
net crude grew kbpd net product export increas
kbpd week ken sill
posit market price neal dingmann
 estim chang storag week
end bcf inject pink dot graph
median bloomberg estim bcf estim
primarili driven respect week weather hdd/
cdd look back histor last year saw bcf
inject hdd/cdd five year averag bcf
inject hdd/cdd pleas see graph follow
page addit histor context well fitzpatrick
energi inc buy miss oil volumes/
capital-expenditure loe better expect srci pre-released
product mboe/d in-lin mboe/
consensu oil cut wors
street expect
loe beat vs con capital-expenditure
miss vs con rais
net effect cfp
drop would expect stock
pressur given new oil cut/capex guidanc
said guidanc tweak neglig rel
upsid fail well fitzpatrick
weak nim contract overdon maintain buy
maintain buy rate revis ep
estim adjust pt lower
nim off-set lower expens nim
peer point econom cycl
compani prudent loan growth launch
new deposit gather vertic focus effici
profit recent price weak repres buy
opportun view jennif demba
bdc underli middl market econom condit
loan volum activ remain favor still low level
seen benefit deal volum despit
growth bdc mostli floating-r loan portfolio
benefit higher short term rate along abil boost
leverag could long-term catalyst favorit
bdc stage cycl arcc tslx
combin portfolio transform arcc and/or
page
reposit effort continu reduct initi
sale subsidiari michael young
reflect nim reset capit return remain strong
 maintain hold rate reduc core
ep estim due
reduc revenu outlook introduc estim
pt
due lower estim industri valuat balanc
sheet reduct aid higher level capit return
substanti nim expans tailwind like
deceler believ core nim expans continu
quarter greater libor increas profit
rotc dividend yield attract michael
nextgen effort appear ahead schedul evidenc
ep michael young
profit strong adjust estim slower revenu
growth maintain buy rate lower pt
adjust oper ep
estim revis reflect
lower revenu off-set lower expens provis ltxb
return upper quartil profit posit near
roa spread incom growth may becom challeng
fierc competit declin mortgag warehous
balanc feel comfort asset qualiti improv
believ area potenti upsid beyond
problem loan improv granular loan growth
maintain hold reiter hold rate reduc
pt due lower industri valuat
revis ep estim
due lower provis expens tax
tbv versu peer median
think share appear close fulli valu given asset
continu support growth maintain buy maintain
buy rate revis ep estim
move pt
reflect lower industri valuat estim revis
reflect higher fee incom lower provis off-set higher
expens tbv versu peer
median share still attract
view given superior ep growth profit profil
page
earn preview ep street
vs vs
vs in-lin shpg model
assum us major biopharma sale benefit robust
outperform vs
defens rotat catalyst hh posit rebat
reimburs environ confer strong
dri powder remain favorit
date head earn biotech indic
aggress btk nbi vs
smid cap coverag coverag stock
commerci biotech tesaro
biomarin consensu revenu estim
increas expect top line beat arri
akao albeit lot focu launch
dynam could miss rest preview
commerci name in-lin lot focu upcom
data tsro strh biotech
sierra oncolog inc srra buy kol call
myelofibrosi model updat mome sierra
oncolog kol call momelotinib/myelofibrosi two
main takeaway broad unmet medic need second
line potenti applic first line mf data
regulatori path unfold next month
transit model/valu peer analysi probabl
adjust dcf base valuat momelotinib
reiter buy pt peter lawson
us major tecentriq global sale mostli
line street chf miss us
bleed share mrk keytruda/azn imfinzi tecentriq
approv nsclc/sclc need break
us monthli sale rang hemlibra global sale
in-lin vs street chf despit us miss
uptak inhibitor patient robust share approv
non-inhibitor import inflect point caus market
share bleed shpg/nvo/sny/pf franchis alecensa
uptak xalkori need lorlatinib protect alk nsclc
result octob close follow et
earn call ep estim
page
unchang respect price target also
remain charl bradi
stock struggl group stock struggl
weak group despit near term demand pattern remain
solidli posit residenti commerci
particularli hurt weak wallboard demand
competit market eas ration larg player
move creat except cheap name
peer like view best gainer
coverag long us head recess
upcom shipment data like neg
prebuy relat wallboard distribut keith
buy ffo
recycl capit austin michael lewi
sl green realti corp hold ffo
result conserv initi guidanc greg
page
oct inc cnat ndr ceo evp cfo exec director ir corp boston
oct synnex corpor ndr ceo head concentrix new york new
oct inc ndr execut vice-president ir corpor develop texa
inc group meet cfo evp global custom oper san jose
shutterfli inc ndr president/ceo vice-president ir treasuri boston
polyon corp ndr cfo vice-president ir canada boston
fti consult inc fti ndr ceo manag director ir corp lo angel
inc ndr cfo global vice-president financ ir boston
suntrust bank inc sti ndr co-chief oper offic director ir assist treasur ir boston new
keyw hold corp keyw ndr ceo ir treasur mid-west new
 ndr evp cfo princip account offic treasur vice-president ir kansa citi
inc group meet ceo cfo west coast
inc ndr ceo cfo vice-president strateg financ new york boston
inc ndr cfo director ir denver kc new
navig consult inc nci ndr ceo cfo director ir kc tx new
novemb lodg game leisur summit boston
oct estimate conf call colorado advoc
andrew jeffrey oscar turner transact process boston
mark hugh insur new york boston new
jennif demba michael young- bank southeast
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
